Tokyo District Court, Reiwa 7 (Wa) 70141, “Inactivated vaccine preparation” (Presiding Judge Nakashima)
更新日：9月30日
Article information
Article type: Case note
Display and classification checked: 2026-09-30
Categories: Patents
Topics: Support requirement / Inventive step / Claim interpretation
Published on this website: 2026-09-29
Tokyo District Court, Reiwa 7 (Wa) 70141, “Inactivated vaccine preparation” (Presiding Judge Nakashima)
Failure to meet the support requirement (+ lack of inventive step)
“Lactococcus garvieae of a serotype that is neither KG− nor KG+” also includes type III Lactococcus garvieae, observed from 2021 onward.
The specification contains no disclosure whatsoever of a vaccine preparation against streptococcosis caused by type III bacteria, and an inactivated type III vaccine is ineffective against streptococcosis caused by type II bacteria.
The patentee argued that “neither KG− nor KG+” in the invention meant only type II. The court rejected that argument: neither type II nor type III was recognized as a classification at the priority date, so the premise that the phrase was understood to mean type II was lacking.
Originally posted on LinkedIn: https://www.linkedin.com/feed/update/urn:li:activity:7510498312488308738/
Related articles and decisions
Updates and corrections
This log starts on 30 September 2026. Display and classification checks are distinct from a review of the legal analysis.
2026-09-30 — Presentation update: added the article type, this change log and a link to consultation options. The existing article text was preserved.
2026-10-01 | Name notation: replaced verified Japanese-script personal names with Roman-letter forms in this English article and its navigation. Legal analysis and original publication date unchanged.
コメント